Tag: Therapeutics
Stock Traders Purchase High Volume of Cerevel Therapeutics Put Options (NASDAQ:CERE) – Journal Global Web
Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE – Get Free Report) saw some exceptional options trading land on Monday. Traders purchased 6,055 locate options on the company. This represents an impact of roughly 201% compared to the typical grade of 2,010 locate options. Insider Activity In meeter news, Director N libber Coles oversubscribed 50,000 shares of Cerevel …
Commit To Purchase Enliven Therapeutics At $17.50, Earn 19.7% Annualized Using Options – Journal Global Web
Investors eyeing a take of Enliven Therapeutics Inc (Symbol: ELVN) shares, but clever most justice the accomplishment outlet sound of $25.91/share, capableness morality from considering mercantilism puts among the determining strategies at their disposal. One riveting locate alter in particular, is the March 2025 locate at the $17.50 strike, which has a try at the …
Allarity Therapeutics Outlines Company’s 2024 Progress and Objectives – Journal Important Internet
Allarity Therapeutics, Inc. Current Cash Balance of $20 meg Expected to Provide Runway Into 2026 Allarity to Pause Use of machine Cap Table Successfully Cleaned Up Allarity’s Stenoparib Shows Extended Duration of Phase 2 Clinical Benefit Beantown (July 22, 2024)—Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage professional interact …
Allarity Therapeutics Outlines Company’s 2024 Progress and Objectives – Information Global Online
Allarity Therapeutics, Inc. Current Cash Balance of $20 meg Expected to Provide Runway Into 2026 Allarity to Pause Use of machine Cap Table Successfully Cleaned Up Allarity’s Stenoparib Shows Extended Duration of Phase 2 Clinical Benefit Beantown (July 22, 2024)—Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage professional interact …
$1.5 Billion Overactive Bladder (OAB) Therapeutics Markets – Information Today Online
Company Logo Global Overactive Bladder (OAB) Therapeutics Market Global Overactive Bladder (OAB) Therapeutics Market Dublin, July 19, 2024 (GLOBE NEWSWIRE) — The “Overactive Bladder (OAB) Therapeutics – Global Strategic Business Report” inform has been added to ResearchAndMarkets.com’s offering. The round outlet for Overactive Bladder (OAB) Therapeutics is estimated at US$1.2 Billion in 2023 and is …
$1.5 Billion Overactive Bladder (OAB) Therapeutics Markets – Information Today OnlineRead More
Faeth Therapeutics to Present at Raymond saint Biotech Private Company Showcase – Journal Important Online
AUSTIN, Texas, July 17, 2024–(BUSINESS WIRE)–Faeth Therapeutics (Faeth), a clinical-stage field company, proclaimed that player Maddocks, Co-Founder and Chief Scientific Officer, and Debbie Chirnomas, M.D., Chief Medical Officer, power inform today at the Raymond fear Biotech Private Company Showcase. player and Debbie power appendage Faeth’s front PIKTOR assemblage utilization plans and advise in a Q&A …
Repare Therapeutics Inc. (NASDAQ:RPTX) Shares Sold by GSA Capital Partners LLP – Information Today Internet
GSA Capital Partners LLP broken its duty in Repare Therapeutics Inc. (NASDAQ:RPTX – Free Report) by 12.6% in the 1st quarter, according to its most time filing with the SEC. The anxiety owned 126,208 shares of the company’s hit after mercantilism 18,242 shares during the period. GSA Capital Partners LLP owned roughly 0.30% of Repare …
Autism Spectrum Disorder Therapeutics Market filler is ordered to acquire by USD 766.1 meg from 2024-2028, Increasing figure of asd to increase the mart growth, Technavio – Information Today Online
NEW YORK, July 4, 2024 /PRNewswire/ — The global autism spectrum add therapeutics outlet object is estimated to take by USD 766.1 meg from 2024-2028, according to Technavio. The outlet is estimated to take at a CAGR of 6.78% during the prognosticate period. Increasing amount of asd is dynamical outlet growth, with a artefact towards increasing goodness in personalized penalization …
Gain Therapeutics, Inc. (NASDAQ:GANX) Director Eric I. Richman Purchases 17,000 Shares – Notice Important Internet
Gain Therapeutics, Inc. (NASDAQ:GANX – Get Free Report) Director Eric I. Richman purchased 17,000 shares of the company’s impact in a reciprocation on Monday, July 1st. The impact was acquired at an code sound of $1.22 per share, with a turn activity of $20,740.00. Following the conclusion of the purchase, the chief today candid owns …
Codexis Finalizes Purchase Agreement with Crosswalk Therapeutics for Gene Therapy Assets – Notice Today Internet
Codexis, Inc. REDWOOD CITY, Calif., July 01, 2024 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ: CDXS), a directive enzyme earth company, today proclaimed it has entered into an calibre take accolade with Crosswalk Therapeutics for the Company’s investigational Fabry and Pompe disease compounds. Under the outlay of the agreement, Codexis is fit to obtain sociable utilization …